F J Montz

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi Significance of "normal" endometrial cells in cervical cytology from asymptomatic postmenopausal women receiving hormone replacement therapy
    F J Montz
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Hospital and Medical Institutions, 600 North Wolfe Street, Baltimore, Maryland 21287 1248, USA
    Gynecol Oncol 81:33-9. 2001
  2. ncbi Impact of increasing Papanicolaou test sensitivity and compliance: a modeled cost and outcomes analysis
    F J Montz
    Kelly Gynecologic Oncology Service, The Johns Hopkins Hospital and Medical Institutions, Baltimore, Maryland 21287 1248, USA
    Obstet Gynecol 97:781-8. 2001
  3. ncbi The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma
    R E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 1248, USA
    Gynecol Oncol 81:92-9. 2001
  4. ncbi A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells
    H Naora
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205 2196, USA
    Proc Natl Acad Sci U S A 98:4060-5. 2001
  5. ncbi Prevention of adhesion formation after radical oophorectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 99:301-8. 2005
  6. ncbi Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator
    R E Bristow
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 1248, USA
    Gynecol Oncol 83:39-48. 2001
  7. ncbi Leiomyomatosis peritonealis disseminata and ovarian Brenner tumor associated with tamoxifen use
    R E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 1248, USA
    Int J Gynecol Cancer 11:312-5. 2001
  8. ncbi Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease
    R E Bristow
    Department of Gynecology and Obstetrics, Kelly Gynecologic Oncology Service, Baltimore, MD 21287, USA
    Gynecol Oncol 81:279-86. 2001
  9. ncbi Ablation of metastatic ovarian carcinoma with the argon beam coagulator: pathologic analysis of tumor destruction
    R E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 83:49-55. 2001
  10. ncbi Management of pelvic hemorrhage
    R S Tomacruz
    Department of Gynecology and Obstetrics The Johns Hopkins Hospital and Medical Institutions, Baltimore, Maryland 21287, USA
    Surg Clin North Am 81:925-48. 2001

Collaborators

Detail Information

Publications22

  1. ncbi Significance of "normal" endometrial cells in cervical cytology from asymptomatic postmenopausal women receiving hormone replacement therapy
    F J Montz
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Hospital and Medical Institutions, 600 North Wolfe Street, Baltimore, Maryland 21287 1248, USA
    Gynecol Oncol 81:33-9. 2001
    ..The aim of this study is to assess the significance of normal endometrial cells identified in screening Pap smears from asymptomatic postmenopausal women taking hormone replacement therapy (HRT)...
  2. ncbi Impact of increasing Papanicolaou test sensitivity and compliance: a modeled cost and outcomes analysis
    F J Montz
    Kelly Gynecologic Oncology Service, The Johns Hopkins Hospital and Medical Institutions, Baltimore, Maryland 21287 1248, USA
    Obstet Gynecol 97:781-8. 2001
    ..To model the impact of increasing screening compliance or implementing liquid-based cytology in populations with known compliance patterns and risk profiles on rates of detection of cervical precancers...
  3. ncbi The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma
    R E Bristow
    The Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 1248, USA
    Gynecol Oncol 81:92-9. 2001
    ..The aim of this study was to evaluate the survival impact of cytoreductive surgery and other prognostic determinants in patients with Stage IV uterine papillary serous carcinoma (UPSC)...
  4. ncbi A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells
    H Naora
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205 2196, USA
    Proc Natl Acad Sci U S A 98:4060-5. 2001
    ..These results reveal HOXB7 as a tumor antigen whose up-regulated expression could play a significant role in promoting growth and development of ovarian carcinomas...
  5. ncbi Prevention of adhesion formation after radical oophorectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Phipps 281, Baltimore, MD 21287, USA
    Gynecol Oncol 99:301-8. 2005
    ....
  6. ncbi Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator
    R E Bristow
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 1248, USA
    Gynecol Oncol 83:39-48. 2001
    ..1-1.0 cm) to microscopic residual disease (complete cytoreduction) among patients with advanced ovarian carcinoma...
  7. ncbi Leiomyomatosis peritonealis disseminata and ovarian Brenner tumor associated with tamoxifen use
    R E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 1248, USA
    Int J Gynecol Cancer 11:312-5. 2001
    ..In the setting of continued hormonal treatment for breast carcinoma, the management of leiomyomatosis peritonealis disseminata presents unique clinical challenges...
  8. ncbi Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease
    R E Bristow
    Department of Gynecology and Obstetrics, Kelly Gynecologic Oncology Service, Baltimore, MD 21287, USA
    Gynecol Oncol 81:279-86. 2001
    ..Pathologic Stage III disease portends a significant risk of distant recurrence. For these patients, administration of adjuvant chemotherapy should be considered in addition to directed RT...
  9. ncbi Ablation of metastatic ovarian carcinoma with the argon beam coagulator: pathologic analysis of tumor destruction
    R E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 83:49-55. 2001
    ....
  10. ncbi Management of pelvic hemorrhage
    R S Tomacruz
    Department of Gynecology and Obstetrics The Johns Hopkins Hospital and Medical Institutions, Baltimore, Maryland 21287, USA
    Surg Clin North Am 81:925-48. 2001
    ....
  11. ncbi Coexistent choriocarcinoma and malignant mixed mesodermal tumor of the uterus
    C P Nguyen
    Department of Gynecology and Obstetrics, The Johns Hopkins Hospital, Baltimore, Maryland 21287, USA
    Gynecol Oncol 79:499-503. 2000
    ..We document the presence of uterine MMMT coexisting with uterine choriocarcinoma that followed an aggressive clinical course and review the possible pathogenesis of this lesion...
  12. ncbi Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer
    C D Hough
    Laboratory of Biological Chemistry, Gerontology Research Center, National Institute on Aging, Baltimore, Maryland 21224, USA
    Cancer Res 60:6281-7. 2000
    ..These experiments provided additional evidence of the relevance of our findings in vivo. The publicly available expression data reported here should stimulate and aid further research in the field of ovarian cancer...
  13. ncbi Aberrant expression of homeobox gene HOXA7 is associated with müllerian-like differentiation of epithelial ovarian tumors and the generation of a specific autologous antibody response
    H Naora
    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Proc Natl Acad Sci U S A 98:15209-14. 2001
    ..These findings associate aberrant HOXA7 expression with the müllerian-like differentiation of epithelial ovarian tumors and suggest diagnostic utility of serum antibodies to HOXA7...
  14. ncbi Ovarian cancer surgery in Maryland: volume-based access to care
    Robert E Bristow
    Department of Biostatistics, Johns Hopkins Oncology Center, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 93:353-60. 2004
    ..To characterize the patterns of primary surgical care for ovarian cancer in a statewide population according to annual surgeon and hospital case volume...
  15. ncbi FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival
    R E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland
    Int J Gynecol Cancer 13:664-72. 2003
    ....
  16. ncbi Inability of immunohistochemistry to predict clinical outcomes of endometrial cancer patients
    D R Gossett
    The University of Michigan Medical Center, Department of Gynecologic Oncology, Ann Arbor, MI 48109 0276, USA
    Int J Gynecol Cancer 14:145-51. 2004
    ..This study characterizes a large series of endometrial carcinomas with previously described markers as well as markers that have not been investigated in endometrial carcinoma...
  17. ncbi Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors
    Marcela G del Carmen
    Department of Gynecology and Obstetrics Department of Oncology, The Johns Hopkins Hospital and Medical Institutions, Baltimore, Maryland, USA
    Cancer 98:1658-63. 2003
    ..Using immunohistochemical methods, we compared the differential expression patterns of various cytokines and growth factors in atypical endometriosis (AE) and EAOC...
  18. ncbi Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    Gynecol Oncol 90:519-28. 2003
    ....
  19. ncbi Micropapillary serous ovarian carcinoma: surgical management and clinical outcome
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 86:163-70. 2002
    ....
  20. ncbi Positron emission tomography for detecting clinically occult surgically resectable metastatic ovarian cancer
    Robert E Bristow
    The Kelly Gynecologic Oncology Service, The Johns Hopkins Medical Institution, Baltimore, Maryland 21287, USA
    Gynecol Oncol 85:196-200. 2002
    ....
  21. ncbi Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis
    Robert E Bristow
    Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD 21287 1248, USA
    J Clin Oncol 20:1248-59. 2002
    ..To evaluate the relative effect of percent maximal cytoreductive surgery and other prognostic variables on survival among cohorts of patients with advanced-stage ovarian carcinoma treated with platinum-based chemotherapy...
  22. ncbi Struma ovarii associated with pseudo-Meigs' syndrome and elevated serum CA 125
    Julie J Huh
    Department of Gynecology and Obstetrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Gynecol Oncol 86:231-4. 2002
    ..CONCLUSION: Struma ovarii is a rare cause of ascites, hydrothorax, and an elevated CA 125 level...